Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Myofascial release: Myofascial release: The treatment is based on the technique proposed by Pilat, A (8). Four maneuvers are selected for the perinodal and upper thoracic region. They w
Sponsors
Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
Eligibility
Inclusion criteria
Inclusion criteria: 1. Consenting women above 18 years of age with breast cancer undergone breast cancer surgery followed by radiotherapy. 2. Up to stage 1 lymphedema 3. Pain following radiotherapy along with one or more of the following symptoms: heaviness, numbness, oppression, stiffness, alterations in the function, or mobility of the shoulder
Exclusion criteria
Exclusion criteria: 1. Women with muscle or tendon injuries in the ipsilateral arm and/or neck. 2. Skin conditions (Local or generalized infection, eczema, psoariasis, etc) which will make myofascial release difficult. 3. Circulatory pathologies (thrombus, embolus of upper limb, on anticoagulants). 4. Surgical history in the ipsilateral shoulder, neck, or chest. 5. Participating in another clinical trial that interferes with the primary and/or secondary outcome of this trial. 6. Breast cancer partially treated elsewhere.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the short and mid-term effectiveness of breast cancer specific myofascial release and manual lymphatic drainage with respect to: 1. Pain in the chest wall and upper limb assessed by visual analogue scale 2. Mobility of the shoulder joint assessed using a goniometer. Timepoint: Three assessment 1. before beginning of the treatment (T0) 2. After completion of the treatment 4 weeks (T1). 3. Follow-up 1 month after completion of the treatment (T2). | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the short and mid-term effects of breast cancer specific myofascial release compared to manual lymphatic drainage in terms of 1. Functionality of the upper limb assesed using Disability of Arm, shoulder and Hand (DASH) score 2. Quality of life assessed using functional assessment of cancer and Arm subscle (FACT B4) Questionnaire Timepoint: Three assessment 1. before beginning of the treatment (T0) 2. After completion of the treatment 4 weeks (T1). 3. Follow-up 1 month after completion of the treatment (T2). | — |
Countries
India
Contacts
Public ContactUday Shamrao Kumbhar
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
Outcome results
None listed